Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Aug 23, 2018 |
Director, President and CEO
Trans History: 29
|
Director, President and CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 1,630 | -- | 1,630 |
Aug 23, 2018 |
Chief Scientific Officer
Trans History: 21
|
Chief Scientific Officer | Form 4 | Conversion of derivative security | 1,231 | -- | 8,585 |
Feb 15, 2024 |
CHIEF OPERATING OFFICER
Trans History: 19
|
CHIEF OPERATING OFFICER | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,229 | $1.27 | 48,644 |
Feb 15, 2024 |
CHIEF MEDICAL OFFICER
Trans History: 12
|
CHIEF MEDICAL OFFICER | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,081 | $1.27 | 31,487 |
Aug 23, 2018 |
Chief Operating Officer
Trans History: 19
|
Chief Operating Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 815 | $6.12 | 815 |
Aug 23, 2018 |
Chief Operating Officer
Trans History: 19
|
Chief Operating Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 815 | -- | 815 |
Feb 15, 2024 |
GENERAL COUNSEL
Trans History: 4
|
GENERAL COUNSEL | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 402 | $1.27 | 3,525 |
Nov 29, 2021 |
Director, President and CEO
Trans History: 29
|
Director, President and CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 150 | $3.98 | 5,025 |
Mar 05, 2024 |
Director, PRESIDENT AND CEO
Trans History: 29
|
Director, PRESIDENT AND CEO | Form 4 | Other acquisition or disposition | -- | -- | 502 |
Sep 20, 2023 |
Chief Financial Officer
Trans History: 2
|
Chief Financial Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.